潍坊医学院学报
濰坊醫學院學報
유방의학원학보
JOURNAL OF WEIFANG MEDICAL COLLEGE
2014年
5期
360-362
,共3页
右美托咪定%布比卡因%毒性%中枢神经系统
右美託咪定%佈比卡因%毒性%中樞神經繫統
우미탁미정%포비잡인%독성%중추신경계통
Dexmedetomidine%Bupivacaine%Toxicity%Central nervous system
目的:观察右美托咪定对大鼠布比卡因中枢神经系统( CNS )毒性的影响。方法 SD大鼠30只,随机分为3组,每组10只:布比卡因组( B组)、右美托咪定5μg/kg +布比卡因组( DB1组)、右美托咪定10μg/kg +布比卡因组( DB2组)。 DB1,DB2组于输注布比卡因前10min 分别静脉输注右美托咪定5μg/kg,10μg/kg,B组输注等量0.9%氯化钠溶液,其后各组以2mg/(kg· min)速率静脉输注0.75%布比卡因,至大鼠出现惊厥时停药。持续监测平均动脉压(MAP)和心率(HR),于泵注布比卡因前、抽搐时采集动脉血进行血气分析,记录大鼠抽搐时布比卡因的用量。结果3组大鼠出现抽搐时的MAP均显著高于泵注布比卡因前( P<0.05),HR均显著慢于泵注布比卡因前(P<0.05)。 B组大鼠出现惊厥时布比卡因用量为(5.6±1.2)mg/kg,与B组比较,DB1组、DB2组布比卡因用量[(7.7±1.4)mg/kg,(7.8±1.1mg/kg)]显著增大(P<0.05),但DB1组和DB2组之间差异无显著性(P>0.05)。结论预注右美托咪定可提高布比卡因诱发大鼠CNS毒性的阈值,减轻CNS毒性,但与右美托咪定剂量无关。
目的:觀察右美託咪定對大鼠佈比卡因中樞神經繫統( CNS )毒性的影響。方法 SD大鼠30隻,隨機分為3組,每組10隻:佈比卡因組( B組)、右美託咪定5μg/kg +佈比卡因組( DB1組)、右美託咪定10μg/kg +佈比卡因組( DB2組)。 DB1,DB2組于輸註佈比卡因前10min 分彆靜脈輸註右美託咪定5μg/kg,10μg/kg,B組輸註等量0.9%氯化鈉溶液,其後各組以2mg/(kg· min)速率靜脈輸註0.75%佈比卡因,至大鼠齣現驚厥時停藥。持續鑑測平均動脈壓(MAP)和心率(HR),于泵註佈比卡因前、抽搐時採集動脈血進行血氣分析,記錄大鼠抽搐時佈比卡因的用量。結果3組大鼠齣現抽搐時的MAP均顯著高于泵註佈比卡因前( P<0.05),HR均顯著慢于泵註佈比卡因前(P<0.05)。 B組大鼠齣現驚厥時佈比卡因用量為(5.6±1.2)mg/kg,與B組比較,DB1組、DB2組佈比卡因用量[(7.7±1.4)mg/kg,(7.8±1.1mg/kg)]顯著增大(P<0.05),但DB1組和DB2組之間差異無顯著性(P>0.05)。結論預註右美託咪定可提高佈比卡因誘髮大鼠CNS毒性的閾值,減輕CNS毒性,但與右美託咪定劑量無關。
목적:관찰우미탁미정대대서포비잡인중추신경계통( CNS )독성적영향。방법 SD대서30지,수궤분위3조,매조10지:포비잡인조( B조)、우미탁미정5μg/kg +포비잡인조( DB1조)、우미탁미정10μg/kg +포비잡인조( DB2조)。 DB1,DB2조우수주포비잡인전10min 분별정맥수주우미탁미정5μg/kg,10μg/kg,B조수주등량0.9%록화납용액,기후각조이2mg/(kg· min)속솔정맥수주0.75%포비잡인,지대서출현량궐시정약。지속감측평균동맥압(MAP)화심솔(HR),우빙주포비잡인전、추휵시채집동맥혈진행혈기분석,기록대서추휵시포비잡인적용량。결과3조대서출현추휵시적MAP균현저고우빙주포비잡인전( P<0.05),HR균현저만우빙주포비잡인전(P<0.05)。 B조대서출현량궐시포비잡인용량위(5.6±1.2)mg/kg,여B조비교,DB1조、DB2조포비잡인용량[(7.7±1.4)mg/kg,(7.8±1.1mg/kg)]현저증대(P<0.05),단DB1조화DB2조지간차이무현저성(P>0.05)。결론예주우미탁미정가제고포비잡인유발대서CNS독성적역치,감경CNS독성,단여우미탁미정제량무관。
Objective To investigate the effects of dexmedetomidine pretreatment on bupivacaine associated toxicity to the central nervous system(CNS) in rats.Methods Thirty SD rats were randomly assigned to 3 groups(n=10 ):bupivacaine group ( B group ) , dexmedetomidine 5μg/kg+bupivacaine group ( DB1 group ) and dexmedetomidine 10μg/kg+bupivacaine group ( DB2 group ) .5μg/kg or 10μg/kg dexmedetomidine was given intravenously respectively in DB1 or DB2 group 10 min before bupivacaine infusion whereas equal volume of normal saline was injected instead in the B group.Rats in 3 groups received continuous infusion of bupivacaine at 2mg/(kg· min).Mean arterial pressure (MAP) and heart rate(HR) were monitored.Arterial blood was drawn before the beginning of local anesthetic infusion and at the onset of convulsions to determine blood gas tensions and pH .The amount of bupivacaine infused was ealculat-ed at the onset of convulsion .Results The MAP values were significantly increased and the HR was significantly de-creased at the onset of convulsion in all groups (P<0.05).In the DB1 and DB2 group,the amounts of bupivacaine cau-sing convulsion were(7.7 ±1.4)mg/kg,(7.8 ±1.1)mg/kg respectively,which were significantly higher than those in the B group(5.6 ±1.2mg/kg)(P<0.05).Conclusion Pretreatmaent with dexmedetomidine can raise the threshold for CNS toxicity and reduce toxicity induced by bupivacaine in rats ,whereas the effect is not dose-dependent .